InsiderTrades

Form 4 for JNJ Johnson & Johnson

Accepted 2026-02-06 17:46:50 ET · period of report 2026-02-05 · accession 0001950802-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-06 17:46 2026-02-05 JNJ Forminard Elizabeth EVP, CLO M - OptEx $129.51 +8,921 21.8K +69% +$1.16M
D 2026-02-06 17:46 2026-02-05 JNJ Forminard Elizabeth EVP, CLO F - Tax $237.90 -6,226 15.5K -29% -$1.48M
D 2026-02-06 17:46 2026-02-05 JNJ Forminard Elizabeth EVP, CLO M - OptEx $129.51 -8,921 0 -100% -$1.16M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-05 M A 8,921 $129.51 21,774 D — —
2 Common Common Stock 2026-02-05 F D 6,226 $237.90 15,548 D — — (F1) This transaction was executed in multiple trades at prices ranging from $237.89 to $237.935. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Derivative Employee Stock Options (Right to Buy) 2026-02-05 M D 8,921 $129.51 0 D $129.51 · 2021-02-12 to 2028-02-11 8,921 Common Stock (F2) Vested and exercisable on the third anniversary of the date of the grant.